Acute behavioural effects of bupropion and naltrexone, alone and in combination, in non-deprived male rats presented with palatable mash

Anti-obesity drugs: past, present and future

(2012) R. J. Rodgers et al.   Disease Models & Mechanisms

Animal models to explore the effects of CNS drugs on food intake and energy expenditure

(2012) Steven P. Vickers et al.   NEUROPHARMACOLOGY

What is the prognosis for new centrally-acting anti-obesity drugs?

(2012) David J. Heal et al.   NEUROPHARMACOLOGY

Brainstem sensing of meal-related signals in energy homeostasis

(2012) Andrew A. Young   NEUROPHARMACOLOGY

CNS regulation of appetite

(2012) Joanne A. Harrold et al.   NEUROPHARMACOLOGY

Naloxonazine, a specific mu-opioid receptor antagonist, attenuates the increment of locomotor activity induced by acute methamphetamine in mice

(2012) Chih-Cheng Chien et al.   TOXICOLOGY LETTERS

The utility of animal models to evaluate novel anti-obesity agents

(2011) Steven P Vickers et al.   BRITISH JOURNAL OF PHARMACOLOGY

 -Opioid Receptors in the Nucleus Accumbens Shell Region Mediate the Effects of Amphetamine on Inhibitory Control But Not Impulsive Choice

(2011) J. Wiskerke et al.   JOURNAL OF NEUROSCIENCE

Neurochemical and behavioral effects elicited by bupropion and diethylpropion in rats

(2010) Abel Santamaría et al.   BEHAVIOURAL BRAIN RESEARCH

“Weighing in” on synergy: Preclinical research on neurohormonal anti-obesity combinations

(2010) Jonathan D. Roth et al.   BRAIN RESEARCH

The tempted brain eats: Pleasure and desire circuits in obesity and eating disorders

(2010) Kent C. Berridge et al.   BRAIN RESEARCH

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

(2010) Frank L Greenway et al.   LANCET

Pharmacological management of appetite expression in obesity

(2010) Jason C. G. Halford et al.   Nature Reviews Endocrinology

Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial

(2010) Thomas A. Wadden et al.   Obesity

Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents

(2010) Neil E. Paterson et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

New approaches to the pharmacological treatment of obesity: Can they break through the efficacy barrier?

(2010) G.A. Kennett et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Behavioural satiety sequence (BSS): Separating wheat from chaff in the behavioural pharmacology of appetite

(2010) R.J. Rodgers et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders

(2009) David J. Heal et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Night and day: Diurnal differences in the behavioural satiety sequence in male rats

(2009) A.J. Tallett et al.   PHYSIOLOGY & BEHAVIOR

‘Liking’ and ‘wanting’ food rewards: Brain substrates and roles in eating disorders

(2009) Kent C. Berridge   PHYSIOLOGY & BEHAVIOR

Effects of bupropion, alone or coadministered with nicotine, on social behavior in mice

(2008) Carmen Gómez et al.   ADDICTION BIOLOGY

Rational Design of a Combination Medication for the Treatment of Obesity

(2008) Frank L. Greenway et al.   Obesity

Rate-dependent effects of bupropion on nicotine self-administration and food-maintained responding in rats

(2008) D STAIRS et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Effects of acute low-dose combined treatment with naloxone and AM 251 on food intake, feeding behaviour and weight gain in rats

(2008) A.J. Tallett et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Endogenous opioids and cannabinoids: System interactions in the regulation of appetite, grooming and scratching

(2008) A.J. Tallett et al.   PHYSIOLOGY & BEHAVIOR

Behaviourally-selective hypophagic effects of naloxone in non-deprived male rats presented with palatable food

(2007) A TALLETT et al.   BEHAVIOURAL BRAIN RESEARCH